Rebound in prevalence and intensity of Onchocerca volvulus infection five years after cessation of alternative treatment strategies in the Massangam Health District, West Region, Cameroon: need for coordinated and sustained efforts
Authors:
Open Access
- 22 December 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 19 (12) , e0013849
Abstract
Background: The control of onchocerciasis currently relies on yearly distribution of ivermectin to at-risk populations. To tackle onchocerciasis in areas of high transmission (so-called hotspots) and achieve elimination of transmission, several complementary/alternative strategies (biannual ivermectin, doxycycline-based test-and-treat and vector control) were implemented in Massangam Health District (HD) in Cameroon, following World Health Organization (WHO) guidelines. A short-term impact evaluation revealed significant reductions in the endemicity levels in three focal hotspot communities (Makouopsap, Mankakoun, and Njinja-Njingouet). This study aimed to assess the situation of onchocerciasis in the focal hotspot communities five years after the cessation of the short pilot implementation of Alternative Treatment Strategies (ATS). Methodology: A quantitative cross-sectional survey was conducted in December 2023 in three focal hotspot communities of the Massangam Health District. Participants underwent a comprehensive assessment including parasitological examination (skin snipping) to establish Onchocerca volvulus microfilaridermia. Principal findings: The overall prevalence of O. volvulus infection in the three focal communities was 18.7% (95% confidence interval CI: 14.1-24.3), significantly higher in the Mankakoun (30.8%) and Makouopsap (24.0%) communities compared to the Njinja-Njingouet community (7.0%) (p = 0.001). The intensity of infection was 3.136 (standard deviation, SD: 19.3099) mf/ss, ranging from 5.218 mf/ss (Mankakoun community) to 2.840 mf/ss (Njinja-Njingouet community). Parasitological indicators significantly increased five years after the cessation of ATS in all three focal communities (p = 0.0409). Conclusion/Significance: These findings indicate a rebound in onchocerciasis transmission and underscore the need for coordinated and sustained efforts, implemented at the scale of a transmission zone per WHO recommendations, to achieve elimination goals.Keywords
Funding Information
- Bill and Melinda Gates Foundation (INV-047164)
This publication has 30 references indexed in Scilit:
- Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysisThe Lancet Global Health, 2024
- Effects of the suspension of mass drug administration during the COVID-19 pandemic on onchocerciasis prevalence in the Bandjoun and Massangam health districts, West Region of CameroonActa Tropica, 2023
- Evaluating and mitigating the potential indirect effect of COVID-19 on control programmes for seven neglected tropical diseases: a modelling studyThe Lancet Global Health, 2022
- A Second Population-Based Cohort Study in Cameroon Confirms the Temporal Relationship Between Onchocerciasis and EpilepsyOpen Forum Infectious Diseases, 2020
- Alternative treatment strategies to accelerate the elimination of onchocerciasisInternational Health, 2018
- Progress toward elimination of onchocerciasis in the AmericasInternational Health, 2018
- Control of onchocerciasis in Africa: Threshold shifts, breakpoints and rules for eliminationInternational Journal for Parasitology, 2011
- After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continuesTropical Medicine & International Health, 2008
- Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trialThe Lancet, 2005
- Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteriaMicrobes and Infection, 2004